Journal Articles
Adams, A., Kevin, R. C., Macdonald, C., Glass, M., Boyd, R., Connor, M., McGregor, I. S., Havel, C. M., Bright, S. J.,Ventura, M.,Gil, C.,Barratt, M. J., & Gerona, R. R. (2019). Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold hopping analogue of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. Drug Testing and Analysis, 11(2), 279-291.doi: 10.1002/dta.2491
Alammehrjerdi, Z., Briggs, N. E., Biglarian, A., Mokri, A., & Dolan, K. (2019). A randomized controlled trial of brief cognitive behavioral therapy for regular methamphetamine use in methadone treatment. Journal of Psychoactive Drugs, Advance online publication. doi:10.1080/02791072.2019.1578445
Berry, J., Jacomb, I., Lunn, J., Sedwell, A., Shakeshaft, A., Kelly, P. J., Sarrami, P., James, M., Russell, S., Nardo, T., Barker, D., & Holmes, J. (2019). A stepped wedge cluster randomised controlled trial of a cognitive remediation intervention in alcohol and other drug (AOD) residential treatment services. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2044-4
Chan, G., Leung, J., Gartner, C., Yong, H-H., Borland, R., & Hall, W. (2019). Correlates of electronic cigarette use in the general population and among smokers in Australia – Findings from a nationally representative survey. Addictive Behaviors, 95, 6-9. doi:10.1016/j.addbeh.2019.02.012
Chapman, J., Naweed, A., Wilson, C., & Dorrian. J. (2019). Sleep for heart health: Investigating the relationship between work day sleep, days off sleep, and cardiovascular risk in Australian train drivers. Industrial Health. DOI:10.2486/indhealth.2018-0194
Clare, P. J., Dobbins, T. A., & Mattick, R. P. (2019). Causal models adjusting for time-varying confounding - a systematic review of the literature. International Journal of Epidemiology, 48(1), 254-265. doi: 10.1093/ije/dy218
Darke, S., Kaye, S., Duflou, J., & Lappin, J. (2019). Completed suicide among methamphetamine users: A national study. Suicide and Life-Threatening Behavior, 49(1), 328-337. doi: 10.1111/sltb.12442
Day, C. A., Coupland, H., Moensted, M., & Burns, L. (2018). The need for more research and considered debate regarding women-only treatment services: A comment on Neale et al (2018). Addiction, 113(9), 1750-1752. doi:10.1111/add.14364
Degenhardt, L., Bharat, C., Bruno, R., Glantz, M. D., Sampson, N. A. … Kessler, R. C. & on behalf of the WHO World Mental Health Survey Collaborators. (2019). Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys. Addiction, 114(3), 534-552. doi: 10.1111/add.14482
Farrugia, A.C., Fraser, S., Dwyer, R., Fomiatti, R., Neale, J., Dietze, P. and Strang, J. (2019). Take-home naloxone and the politics of care. Sociology of health and illness, 41, (2), pp. 427-443. DOI: 10.1111/1467-9566.12848
Link: https://doi.org/10.1111/1467-9566.12848
Farrugia, A.C., Neale, J., Dwyer, R., Fomiatti, R., Fraser, S., Strang, J. and Dietze, P. (2019). Conflict and communication: Managing the multiple affordances of take-home naloxone administration events in Australia. Addiction Research & Theory. DOI: 10.1080/16066359.2019.1571193.
Link: http://dx.doi.org/10.1080/16066359.2019.1571193
Fernández-Calderón, F., Díaz-Batanero, C., Barratt, M. J., & Palamar, J. J. (2019). Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs. Drug and Alcohol Review, 38(1), 57-67. doi:10.1111/dar.12868
Gisev, N., Nielsen, S., Campbell, G., Santo, T., Mant, A., Bruno, R., Cohen, M., Hall, W. D., Larance, B., Lintzeris, N., Farrell, M., & Degenhardt, L. (2019). Antidepressant use among people prescribed opioids for chronic noncancer pain. Pain Medicine, Advance online publication, 1-9. doi:10.1093/pm/pnz009
Gisev, N., Pearson, S.-A., Larance, B., Larney, S., Blanch, B., & Degenhardt, L. (2019). A population-based study of transdermal fentanyl initiation in Australian clinical practice. European Journal of Clinical Pharmacology, 75(3), 401-408. doi:10.1007/s00228-018-2588-0
Jacka, B., Kemp, R., Degenhardt, L., Peacock, A., Clare, P., Bruno, R., Dev, A., Sotade, O., & Larance, B. (2019). Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015. Drug Alcohol Review, Advance online publication. doi:10.1111/dar.12908
Jacobs, N. I., Montebello, M., Monds, L. A., & Lintzeris, N. (2019). Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids. Australasian Psychiatry, 27(1), 80-85. doi:10.1177/1039856218803675
Kwon, J. A., Iversen, J., Law, M., Dolan, K., Wand, H., & Maher, L. (2019). Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016. Drug and Alcohol Dependence, 197, 108-114. doi:10.1016/j.drugalcdep.2018.11.033
Lalic, S., Ilomäki , J., Bell, J. S., Korhonen, M. J., & Gisev, N. (2019). Prevalence and incidence of prescription opioid analgesic use in Australia. British Journal of Clinical Pharmacology, 85(1), 202-215. doi:10.1111/bcp.13792
Larney, S., & Hall, W. (2019). A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA. The Lancet Public Health, 4(2), e77-e78. doi:10.1016/S2468-2667(19)30001-5
Liu, Q., Hu, L., Smith, J. L., & Mewton, L. R. (2019). Can inhibitory training produce reductions in drinking? Evaluating the influence of the control condition. Journal of Studies on Alcohol and Drugs, 80(1), 96-101. doi:10.15288/jsad.2019.80.96
Moore, D., Hart, A.C., Fraser, S. and Seear, K. (2019). Masculinities, practices and meanings: A critical analysis of recent literature on the use of performance and image-enhancing drugs among men. Health. DOI: 10.1177/1363459319838595.
Link: http://dx.doi.org/10.1177/1363459319838595
Naghavi, M, on behalf of the Global Burden of Disease Self-Harm Collaborators, Degenhardt, L. (2019). Global, regional, and national burden of suicide mortality 1990 to 2016: a systematic analysis for the Global Burden of Disease Study 2016. BMJ, Advance online publication. doi:10.1136/bmj.194
Najman, J.M., Plotnikova, M., Horwood, J., Silins, E., Fergusson, D.M., Patton, G., Olsson, C.A., Hutchinson, D., Degenhardt, L., Tait, R.J., Youssef, G., Borschmann, R., Coffey, C., Toumbourou, J. and Mattick, R. (2019). Does adolescent heavier alcohol use predict young adult aggression and delinquency? Parallel analyses from four Australasian cohort studies. Aggressive Behavior. DOI: 10.1002/ab.21828.
Link: https://doi.org/10.1002/ab.21828
Palamar, J. J., & Barratt, M. J. (2019). Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in anelectronic dance music scene in New York City. Drug and Alcohol Review, 37(1), 42-49. doi: 10.1111/dar.12882
Peacock, A., Larance, B., Bruno, R., Pearson, S. A., Buckley, N. A., Farrell, M., & Degenhardt, L. (2019). Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations. Addiction, 114 (3) 404-405. doi: 10.1111/add.14556
Peacock, A., Larance, B., Bruno, R., Pearson, S.-A., Buckley, N. A., Farrell, M., & Degenhardt, L. (2019). Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting. Addiction, 114(3), 389-399. doi:10.1111/add.14380
Rapsey, C. M., Wells, J. E., Bharat, C., Glantz, M., Kessler, R. C., & Scott, K. M. (2019). Transitions through stages of alcohol use, use disorder and remission: Findings from Te Rau Hinengaro, the New Zealand Mental Health Survey. Alcohol and Alcoholism, 54(1), 87-96. doi:10.1093/alcalc/agy069
Ritter, A., & van de Ven, K. (2019). Is health or social welfare the right question? Response to commentaries. Drug and Alcohol Review, Advance online publication. doi:doi:10.1111/dar.12900
Ritter, A., Chalmers, J., & Gomez, M. (2019). Measuring unmet demand for alcohol and other drug treatment: The application of an Australian population-based planning model. Journal of Studies on Alcohol and Drugs, Supplement, (S.18), 42-50. doi:10.15288/jsads.2019.s18.42
Ritter, A., Mellor, R., Chalmers, J., Sunderland, M., & Lancaster, K. (2019). Key considerations in planning for substance use treatment: estimating treatment need and demand. Journal of Studies on Alcohol and Drugs, Supplement, (S.18), 22-30. doi:10.15288/jsads.2019.s18.22
Rowe, R., Ansara, G., Jaworski, A., Higgs, P., & Clare, P. J. (2018). What is the alcohol, tobacco, and other drug prevalence among culturally and linguistically diverse groups in hte Australian population? A national study of prevalence, harms, and attitudes. Journal of Ethnicity in Substance Abuse, Advance online publication, 1-18. doi:10.1080/15332640.2018.1484310
Schaffer, A. L., Karanges, E. A., Buckley, N. A., Wilson, A., Degenhardt, L., & Larance, B. (2019). Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study. Pharmacoepidemiology and Drug Safety, 28(1), 97-105. doi: 10.1002/pds.4683
Sharmin, S., Kypri, K., Wadolowski, M., Bruno, R., Khanam, M., Aiken, A., Hutchinson, D., Najman, J.M., Slade, T., McBride, N., Attia, J., Palazzi, K., Oldmeadow, C. and Mattick, R. (2019). Parental hazardous drinking and their children's alcohol use in early and mid-adolescence: Prospective cohort study. European Journal of Public Health, ckz029. DOI: 10.1093/eurpub/ckz029.
Link: https://doi.org/10.1093/eurpub/ckz029
Shatte, A. B. R., Hutchinson, D. M., & Teague, S. J. (2019). Machine learning in mental health: a scoping review of methods and applications. Psychological Medicine, Advance online publication, 1-23. doi:10.1017/S0033291719000151
Taylor, N., Mayshak, R., Curtis, A., Coomber, K., Chikritzhs, T.N. and Miller, P.G. (2019). Investigating and validating methods of monitoring foot-traffic in night-time entertainment precincts in Australia. International Journal of Drug Policy, 66, pp. 23-29. DOI: 10.1016/j.drugpo.2019.01.009.
Link: http://dx.doi.org/10.1016/j.drugpo.2019.01.009
Voce, A., Calabria, B., Burns, R.,Castle, D., & McKetin, R. (2019). A systematic review of the symptom profile and course of methamphetamine-associated psychosis. Substance Use and Misuse, Advance online publication. doi:10.1080/10826084.2018.1521430
Williamson, A., Barker, D., Green, S., D'Este, C., Davies, H. T. O., Jorm, L., Shakeshaft, A., Rudge, S., Redman, S. (2019). Increasing the capacity of policy agencies to use research findings: A stepped-wedge trial. Health Research Policy and Systems, 17(1). doi:10.1186/s12961-018-0408-8
Reports
Grigg, J. & Lenton, S. (2019). Shifting trends in the Perth ecstasy market: Harm reduction implications. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Linkt: https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Drug%20Trends%20Bulletin_WA_Ecstasy%20market.pdf